Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis

Oncogene. 2009 Apr 30;28(17):1892-903. doi: 10.1038/onc.2009.34. Epub 2009 Mar 30.

Abstract

Co-amplification at chromosomes 8p11-8p12 and 11q12-11q14 occurs often in breast tumors, suggesting possible cooperation between genes in these regions in oncogenesis. We used high-resolution array comparative genomic hybridization (array CGH) to map the minimal amplified regions. The 8p and 11q amplicons are complex and consist of at least four amplicon cores at each site. Candidate oncogenes mapping to these regions were identified by combining copy number and RNA and protein expression analyses. These studies also suggested that CCND1 at 11q13 induced expression of ZNF703 mapping at 8p12, which was subsequently shown to be mediated by the Rb/E2F pathway. Nine candidate oncogenes from 8p12 and four from 11q13 were further evaluated for oncogenic function. None of the genes individually promoted colony formation in soft agar or collaborated with each other functionally. On the other hand, FGFR1 and DDHD2 at 8p12 cooperated functionally with MYC, whereas CCND1 and ZNF703 cooperated with a dominant negative form of TP53. These observations highlight the complexity and functional consequences of the genomic rearrangements that occur in these breast cancer amplicons, including transcriptional cross-talk between genes in the 8p and 11q amplicons, as well as their cooperation with major pathways of tumorigenesis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Breast Neoplasms / genetics*
  • Breast Neoplasms / pathology
  • Carrier Proteins / genetics
  • Cell Line, Tumor
  • Chromosomes, Human, Pair 11 / genetics*
  • Chromosomes, Human, Pair 8 / genetics*
  • Comparative Genomic Hybridization
  • Cyclin D1 / genetics
  • Epistasis, Genetic
  • Female
  • Gene Amplification*
  • Gene Dosage
  • Gene Expression Regulation, Neoplastic
  • Genetic Predisposition to Disease
  • Humans
  • Neoplastic Stem Cells / metabolism
  • Neoplastic Stem Cells / pathology
  • Oncogene Protein p55(v-myc) / genetics
  • Oncogenes / genetics*
  • Phospholipases / genetics
  • RNA, Small Interfering / genetics
  • Receptor, Fibroblast Growth Factor, Type 1 / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction / genetics
  • Transfection
  • Tumor Suppressor Protein p53 / genetics

Substances

  • CCND1 protein, human
  • Carrier Proteins
  • Oncogene Protein p55(v-myc)
  • RNA, Small Interfering
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • ZNF703 protein, human
  • Cyclin D1
  • FGFR1 protein, human
  • Receptor, Fibroblast Growth Factor, Type 1
  • Phospholipases
  • DDHD2 protein, human